Genovis AB (publ.) (STO:GENO)

Genovis AB (publ.) Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	32.92	61.5	11.19	24.78	6.45
Depreciation & Amortization	10.45	9.72	6.63	5.77	5.43
Other Operating Activities	-17.03	-6.85	-3.95	-0.39	-4.3
Change in Accounts Receivable	10.27	-8.71	-14.34	0.88	-5.29
Change in Inventory	1.47	-2.35	-0.14	0.47	-3.92
Change in Accounts Payable	-0.95	14.44	-0.32	14.41	5.38
Operating Cash Flow	37.12	67.75	-0.93	45.92	3.76
Operating Cash Flow Growth	-45.22%	-	-	1122.81%	-71.39%
Capital Expenditures	-1.09	-10.44	-2.93	-1.77	-1.43
Divestitures	30.35	-	-	-	-
Sale (Purchase) of Intangibles	-3.71	-2.37	-0.89	-2.72	-19
Investment in Securities	-11.13	-	-	-	-
Investing Cash Flow	14.42	-12.81	-3.83	-4.49	-20.43
Long-Term Debt Repaid	-5.36	-4.51	-3.73	-4.23	-3.77
Net Debt Issued (Repaid)	-5.36	-4.51	-3.73	-4.23	-3.77
Issuance of Common Stock	-	-	-	-	49.57
Financing Cash Flow	-5.36	-4.51	-3.73	-4.23	45.8
Net Cash Flow	46.18	50.43	-8.49	37.2	29.13
Free Cash Flow	36.03	57.31	-3.86	44.15	2.32
Free Cash Flow Growth	-37.13%	-	-	1801.43%	-74.05%
Free Cash Flow Margin	27.44%	36.03%	-3.73%	47.13%	3.80%
Free Cash Flow Per Share	0.55	0.88	-0.06	0.67	0.04
Cash Interest Paid	3.96	2.26	0.34	0.15	0.99
Levered Free Cash Flow	24.74	29.75	-2.79	28.32	-19.05
Unlevered Free Cash Flow	27.21	31.16	-2.57	28.32	-18.43
Change in Net Working Capital	-3.16	0.05	14.02	-12.56	6.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.